Precio de cierre
Otros sitios de cotización
|
||
- EUR | - |
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Deborah Baron
PSD | President | 55 | 17/11/21 |
Kathleen Large
CTO | Chief Tech/Sci/R&D Officer | 64 | 01/01/19 |
Andrew Muratore
BRD | Director/Board Member | - | 17/11/21 |
Jeff Settleman
PRN | Corporate Officer/Principal | - | - |
Aaron Schimmer
PRN | Corporate Officer/Principal | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Deborah Baron
PSD | President | 55 | 17/11/21 |
Andrew Muratore
BRD | Director/Board Member | - | 17/11/21 |
Información de la empresa
Trillium Therapeutics ULC
1055 West Georgia Street
V6E 3P3, Vancouver
+
http://www.trilliumtherapeutics.comSector
- Bolsa de valores
- Acciones
- Acción TRIL
- Acción R5W
- Empresa Stem Cell Therapeutics Corp.